While several preclinical models of cancer cachexia are available, the ApcMin/+ mouse model of cancer cachexia exhibits chronically elevated plasma IL-6 levels, muscle wasting, and liver metabolic dysfunction [27, 28, 36]. Here, IL6 is linked to cancer.